Theodore Hong, MD
Open to Accrual
To determine if overall survival (OS) is different for hepatocellular carcinoma patients treated with protons compared to photons.
Patients with pathologically (histologically or cytologically) or radiographically proven (based on the American Association for the Study of Liver Diseases criteria) unresectable or locally recurrent hepatocellular cancer
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.